Atlas Trials

Pharmacokinetics and Pharmacodynamics of Sugammadex in Reversal of Vecuronium-induced Neuromuscular Blockade

Clinical trial NCT04131218 · UNKNOWN

Trial details

NCT number
NCT04131218
Sponsor
Guangzhou General Hospital of Guangzhou Military Command
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
PharmacokineticsPharmacodynamics
Start date
2019-07-16
Primary completion
2020-07-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.